Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Joyzyme GroupHKSE:08622 +3.13%40 Days Inventory is 91.99 as of Dec. 2025, which is 27% below its 10-year median of 125.60. GuruFocus rates HKSE:08622 with a GF Score™ of 40/100 and a GF Value™ of HK$0.17 (Fairly Valued). The stock has 4 warning signs investors should review. Among 918 Drug Manufacturers companies, Joyzyme Group ranks better than 75.93% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Joyzyme Group's Average Total Inventories for the
six
months ended in Dec. 2025 was HK$3.68 Mil. Joyzyme Group's Cost of Goods Sold for the
six
months ended in Dec. 2025 was HK$7.29 Mil.
Hence, Joyzyme Group's Days Inventory for the
six
months ended in Dec. 2025 was 91.99.
The historical rank and industry rank for Joyzyme Group's Days Inventory or its related term are showing as below:
HKSE:08622'
s Days Inventory Range Over the Past 10 Years
Min: 96.26 Med: 125.6 Max: 167.68
Current: 107.82
During the past 11 years, Joyzyme Group's highest Days Inventory was 167.68. The lowest was 96.26. And the median was 125.60.
HKSE:08622's Days Inventory is ranked better than 75.93% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.705
vs HKSE:08622: 107.82
Joyzyme Group's Days Inventory
declined
from Dec. 2024 (120.39) to Dec. 2025 (91.99).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Joyzyme Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.98.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Joyzyme Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.21.
Joyzyme Group (HKSE:08622) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Joyzyme Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Joyzyme Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Joyzyme Group Days Inventory Related Terms
Joyzyme Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Joyzyme Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Joyzyme Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Joyzyme Group Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Joyzyme Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Joyzyme Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Joyzyme Group (HKSE:08622) has a Days Inventory of 91.99 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Joyzyme Group and its competitors. This is 27% below median its historical median of 125.60. Over the past decade, Joyzyme Group's Days Inventory has ranged from 96.26 to 167.68. According to the industry distribution chart, Joyzyme Group ranks #221 out of 918 companies in the Drug Manufacturers industry, placing it in the top 24.1%.
Is Joyzyme Group's Days Inventory too high?
Joyzyme Group's current Days Inventory of 91.99 is 27% below median its 10-year median of 125.60. Over the past 10 years, this metric has ranged from a low of 96.26 to a high of 167.68. The Drug Manufacturers industry median Days Inventory is 164.71. Joyzyme Group's value of 91.99 is 44.1% below this industry median. Based on the distribution chart, Joyzyme Group ranks #221 out of 918 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Joyzyme Group has a GF Score™ of 40/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Joyzyme Group's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Joyzyme Group ranks #221 out of 918 companies for Days Inventory. This places Joyzyme Group in the top 24% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.71. Joyzyme Group's value of 91.99 is 44.1% below this benchmark. Historically, Joyzyme Group's own Days Inventory has ranged from 96.26 to 167.68 over the past decade. While the company's 10-year median is 125.60 vs. the industry median of 164.71, Joyzyme Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.71, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Joyzyme Group's current Days Inventory of 91.99 is 44.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Joyzyme Group and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Joyzyme Group's current Days Inventory is 91.99, which is 27% below median its own 10-year median of 125.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joyzyme Group stock overvalued right now?
Based on GuruFocus' analysis, Joyzyme Group (HKSE:08622) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.17, compared to a current price of HK$0.17 — trading 2.9% below its estimated fair value. The current Days Inventory is 91.99, which is 27% below median its 10-year median of 125.60 and 44.1% below the Drug Manufacturers industry median of 164.71. Joyzyme Group's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Joyzyme Group (HKSE:08622), the current Days Inventory is 91.99 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Joyzyme Group (HKSE:08622) Overvalued in 2026?
Based on GuruFocus' analysis, Joyzyme Group stock appears to be undervalued.
The current stock price of HK$0.17 is trading 2.9% below its estimated GF Value™ of HK$0.17.
GuruFocus considers Joyzyme Group to be Fairly Valued.
Key valuation signals for HKSE:08622:
Days Inventory: 91.99 (27% below median its 10-year median of 125.60)
GF Value™: HK$0.17 vs. price of HK$0.17 (2.9% below fair value)
Industry Position: 44.1% below the Drug Manufacturers median (#221 of 918)
No single metric tells the full story. See the HKSE:08622 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo.16 Yinkui Road, 1-3 floor and 5th floor, Building D, Shenzhen Junxuan, Kui Xin Community, Kui Chong Office, Dapeng New District, Shenzhen, CHN
Joyzyme Group Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in research and development, manufacture, marketing, and sale of biological reagents and auxiliary reproductive supplies and equipment, and healthcare products and supplements in the People's Republic of China (the PRC). It operates in two segments: Biological reagents and auxiliary reproductive supplies and equipment, and Healthcare products and supplements. It generates the majority of its revenue from the biological reagents and auxiliary reproductive supplies and equipment segment. Geographically, it generates revenue from the PRC.
40GF Score
Get the complete analysis for HKSE:08622
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08622 has been successfully added to your 
